European Union (EU) Point-of-Care Ultrasound (PoCUS) Device Market Report Provides a Comprehensive Analysis of Market Trends, Technological Advancements, Company Profile and Growth Opportunities
The European Union point-of-care
ultrasound device market is forecasted to generate $230.9 million revenue by
2024, progressing at a CAGR of 6.1% during the forecast period. Factors driving
the growth of this market include increasing prevalence of chronic diseases,
increasing awareness about the benefits of portable ultrasound devices,
technological advancements in PoCUS devices, increasing healthcare expenditure
in the region, and surge in geriatric population, according to P&S
Intelligence.
Anesthesia,
intensive care unit (ICU), emergency medicine, cardiology, vascular and
urology, obstetrics and gynecology (OB/GYN), and musculoskeletal are some major
applications for which PoCUS devices are utilized in the EU market. Among
these, anesthesia is expected to hold the largest share in the European Union
point-of-care ultrasound device market in the coming years, mainly on account
of increasing number of surgeries in the region. Anesthesia is given to a
patient before surgery, and PoCUS devices are used to monitor the needle going
inside the patient’s body, while administering anesthesia. This category is
expected to hold more than 20.0% share in the EU market by 2024, garnering a
CAGR of 7.1% during the forecast period.
Germany is facing
an increase in its geriatric population. This can be substantiated from the
fact that the older population of the country accounted for 28.0% of its total
population in 2017, as reported by the United Nations World Ageing Report,
published in 2017, which is further expected to rise to 37.6% by 2050. This
significant percentage of geriatric population would increase the incidence of
diseases related to old age, thereby creating demand for PoCUS devices in the
country’s point-of-care ultrasound device market.
Further, according
to the Institute for Health Metrics and Evaluation (IHME), cardiovascular
diseases, cancer, and chronic respiratory diseases, accounted for 37%, 27%, and
6% of total deaths, respectively, in Germany. This trend of increasing medical
conditions in the country will provide opportunity to the point-of-care
ultrasound device market players for developing products for faster and better
diagnosis of these diseases.
Moreover,
increasing innovations and awareness in the field of PoCUS is also expected to
generate demand for these devices in the country. For instance, BK Medical
Holding Company Inc. is planning to attend various meetings and conferences,
such as the Annual Congress of the German Society of Anesthesiology and
Intensive Care Medicine (DAC2019) on May, 9–11, 2019; the 70th Annual Meeting
of the German Society of Neurosurgery on May, 12–15, 2019; and the 60th
Urologist Congress 2019 on May, 22–25, 2019; among others. This increasing
awareness among product manufacturers is expected to drive the growth of the
point-of-care ultrasound device market in the coming years.
Make Enquiry
Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=eu-pocus-device-market
Key players
operating in the European Union point-of-care ultrasound device market are
acquiring other players to strengthen their product portfolio and increase
their market share. For instance, in June 2018, Analogic Corporation, the parent
company of BK Medical Holding Company Inc., was acquired by Altaris Capital
Partners LLC, a healthcare investment firm. After the acquisition, Analogic’s
ultrasound product portfolio was reorganized under the brand name BK Medical.
The strategic move was carried out by Analogic Corporation to sustain its
growth in the market.
Other developments
in the European Union
point-of-care ultrasound device market include launch of technologically-advanced
products such as portable/handheld PoCUS devices. For example, in June 2018,
Hologic Inc. announced the availability of Viera portable breast ultrasound
system in Europe and the U.S. This system helps physicians in the early diagnosis
of several diseases. The handheld device provides high-resolution images
directly on a smart device, at the point-of-care, enabling optimization of
clinical workflow and patient pathway.
Comments
Post a Comment